808743-24-0

Basic information

• Product Name: Acetamide, N-(4-hydroxy-2-methyl-6-nitrophenyl)- (9CI)
• Synonyms: Acetamide, N-(4-hydroxy-2-methyl-6-nitrophenyl)- (9CI)
• CAS NO: 808743-24-0
• Molecular Formula: C₉H₁₀N₂O₄
• Molecular Weight: 210.1867
• Product Categories: METHYL
• Mol File: 808743-24-0.mol

Chemical Properties

• Melting Point: 188.5 °C
• Boiling Point: 440.4±45.0 °C(Predicted)
• Appearance: /
• Density: 1.410±0.06 g/cm3(Predicted)
• PKA: 8.34±0.17(Predicted)
• CAS DataBase Reference: Acetamide, N-(4-hydroxy-2-methyl-6-nitrophenyl)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Acetamide, N-(4-hydroxy-2-methyl-6-nitrophenyl)- (9CI)(808743-24-0)
• EPA Substance Registry System: Acetamide, N-(4-hydroxy-2-methyl-6-nitrophenyl)- (9CI)(808743-24-0)

Safety Data

• Hazardous Substances Data: 808743-24-0(Hazardous Substances Data)

Upstream product

• 808743-18-2 4-acetamido-3-methyl-5-nitrophenyl acetate 
• 39495-15-3 4-acetamido-3-methylphenol 
• 120-66-1 N-(2-methylphenyl)acetamide 
• 145823-43-4 diacetyl-4-amino-3-methylphenol 
• 2835-99-6 4-amino-3-methylphenol 

Downstream Products

• 861086-22-8 acetic acid-(4-ethoxy-2-methyl-6-nitro-anilide) 
• 808743-25-1 ethyl 4-[4-(acetylamino)-3-methyl-5-nitrophenoxy]butanoate 
• 808743-58-0 4-(4-amino-3-methyl-5-nitrophenoxy)butanoic acid 
• 808743-60-4 ethyl 4-(3,4-diamino-5-methylphenoxy)butanoate 
• 808743-59-1 ethyl 4-(4-amino-3-methyl-5-nitrophenoxy)butanoate 

Relevant articles and documents

Acylamino-Directed Specific Sequential Difunctionalizations of Anilides via Metal-Free Relay Reactions for p-Oxygen and o-Nitrogen Incorporation

Novel acylamino-directed relay disubstitutions realize the sequential difunctionalizations of anilides (1) under mild and metal-free conditions for the first time. This [bis(trifluoroacetoxy)iodo]benzene (PIFA) and BF3·Et2O promoted straightforward reaction produces a series of p-acetoxyl- or p-alkoxyl-o-nitro-N-arylamides (2), which are key scaffolds of various drugs, functional materials, and bioactive molecules. The flexibility with respect to the functional groups in these products affords this novel protocol excellent versatility for synthetic applications.

BENZIMIDAZOLE COMPOUNDS

The present invention provides novel benzimidazole compounds of the formula (I): wherein each symbol is as defined in the specification, salts thereof and prodrugs thereof, which are useful in treating, for example, the diseases curable through decrease in blood sugar level.